Durmaz, Y. And İlhanlı, İ. 2021. Six month assessment of low dose rituximab in the treatment of rheumatoid arthritis during coronavirus disease 2019 (COVID-19) pandemic. EGYPTIAN RHEUMATOLOGIST , vol.43, no.3 , 253-256.

Durmaz, Y., & İlhanlı, İ., (2021). Six month assessment of low dose rituximab in the treatment of rheumatoid arthritis during coronavirus disease 2019 (COVID-19) pandemic. EGYPTIAN RHEUMATOLOGIST , vol.43, no.3, 253-256.

Durmaz, Yunus, And İlker İlhanlı. "Six month assessment of low dose rituximab in the treatment of rheumatoid arthritis during coronavirus disease 2019 (COVID-19) pandemic," EGYPTIAN RHEUMATOLOGIST , vol.43, no.3, 253-256, 2021

Durmaz, Yunus And İlhanlı, İlker. "Six month assessment of low dose rituximab in the treatment of rheumatoid arthritis during coronavirus disease 2019 (COVID-19) pandemic." EGYPTIAN RHEUMATOLOGIST , vol.43, no.3, pp.253-256, 2021

Durmaz, Y. And İlhanlı, İ. (2021) . "Six month assessment of low dose rituximab in the treatment of rheumatoid arthritis during coronavirus disease 2019 (COVID-19) pandemic." EGYPTIAN RHEUMATOLOGIST , vol.43, no.3, pp.253-256.

@article{article, author={Yunus Durmaz And author={İlker İlhanlı}, title={Six month assessment of low dose rituximab in the treatment of rheumatoid arthritis during coronavirus disease 2019 (COVID-19) pandemic}, journal={EGYPTIAN RHEUMATOLOGIST}, year=2021, pages={253-256} }